Intellia Therapeutics Ownership | Who Owns Intellia Therapeutics?
Intellia Therapeutics Ownership Summary
Intellia Therapeutics is owned by 73.36% institutional investors, 4.51% insiders, and 22.13% retail investors. Ark investment management is the largest institutional shareholder, holding 13.39% of NTLA shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 7.88% of its assets in Intellia Therapeutics shares.
NTLA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Intellia Therapeutics | 73.36% | 4.51% | 22.13% |
| Sector | Healthcare Stocks | 232.80% | 10.63% | -143.43% |
| Industry | Biotech Stocks | 379.48% | 10.37% | -289.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 14.51M | 13.39% | $186.01M |
| Vanguard group | 13.01M | 11.81% | $116.96M |
| Blackrock funding, inc. /de | 12.16M | 11.22% | $155.84M |
| Blackrock | 9.60M | 10.05% | $214.79M |
| State street | 6.92M | 6.39% | $88.75M |
| D. e. shaw | 5.73M | 5.29% | $73.44M |
| Two sigma investments, lp | 4.71M | 4.34% | $60.33M |
| Regeneron pharmaceuticals | 3.70M | 3.42% | $47.47M |
| Baker bros. advisors lp | 2.75M | 2.65% | $47.44M |
| Geode capital management | 2.85M | 2.63% | $36.56M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Regeneron pharmaceuticals | 3.70M | 99.14% | $47.47M |
| Birchview capital, lp | 445.40K | 3.25% | $5.71M |
| Contrarius investment management | 1.92M | 2.68% | $42.87M |
| Ark investment management | 14.51M | 1.45% | $186.01M |
| Contrarius group | 1.91M | 1.39% | $24.51M |
| Orchard capital management | 82.03K | 1.10% | $1.05M |
| Iq eq fund management (ireland) | 724.29K | 0.71% | $9.29M |
| Canal insurance | 230.00K | 0.63% | $2.95M |
| Himension capital (singapore) pte. | 429.54K | 0.42% | $5.51M |
| Opaleye management | 245.00K | 0.41% | $3.14M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma investments, lp | 4.71M | 0.05% | 2.01M |
| Vanguard group | 13.01M | 0.00% | 1.97M |
| Blackrock funding, inc. /de | 12.16M | 0.00% | 1.88M |
| Ubs group | 2.69M | 0.01% | 1.83M |
| Arrowstreet capital, limited partnership | 1.40M | 0.01% | 1.40M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -4.95M |
| Capital investors | - | - | -3.78M |
| Renaissance | - | - | -1.67M |
| Rokos capital management llp | - | - | -1.14M |
| Trexquant investment lp | 270.12K | 0.05% | -857.22K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.40M | 0.01% | 1.40M | $17.91M |
| Vanguard fiduciary trust | 748.10K | 0.00% | 748.10K | $9.59M |
| Farallon capital management | 607.20K | 0.04% | 607.20K | $10.49M |
| Steadfast capital management lp | 365.40K | 0.11% | 365.40K | $6.31M |
| Casdin capital | 355.00K | 0.34% | 355.00K | $4.55M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Activest wealth management | -1.00 |
| Dinuzzo private wealth | -1.00 |
| Jfs wealth advisors | -2.00 |
| Richard w. paul & associates | -2.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 221 | -28.25% | 80,835,304 | -22.43% | 73 | 0.82% | 102 | -32.45% | 72 | -10.00% |
| Sep 30, 2025 | 289 | 1.05% | 103,222,255 | 12.82% | 99 | 1.28% | 143 | -2.72% | 76 | -8.43% |
| Jun 30, 2025 | 290 | -7.05% | 98,735,343 | -2.49% | 95 | 0.99% | 146 | -0.68% | 85 | -10.53% |
| Mar 31, 2025 | 6 | -98.05% | 3,804,135 | -96.17% | 3 | 0.04% | 3 | -98.41% | 1 | -98.55% |
| Dec 31, 2024 | 286 | -2.39% | 92,252,291 | -1.01% | 91 | 1.07% | 178 | 17.11% | 61 | -27.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 9.31M | 7.88% | 333.26K |
| ARK Innovation ETF | 9.90M | 7.30% | 1.96M |
| American Funds SMALLCAP World A | 3.78M | 3.65% | 3.78M |
| Vanguard Total Stock Mkt Idx Inv | 3.67M | 3.11% | 27.28K |
| State Street® SPDR® S&P® Biotech ETF | 4.18M | 3.08% | -41.38K |
| Vanguard US Total Market Shares ETF | 3.17M | 3.06% | 299.88K |
| ARK Genomic Revolution ETF | 3.50M | 2.58% | 487.84K |
| ARK Genomic Revolution | 2.87M | 2.43% | -132.03K |
| Vanguard Small Cap Index | 2.72M | 2.31% | 92.49K |
| iShares Russell 2000 ETF | 2.62M | 1.88% | 22.14K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | BASTA JAMES | EVP, General Counsel | Sell | $16.69K |
| Mar 02, 2026 | Clark Eliana | EVP, Chief Technical Officer | Sell | $8.36K |
| Jan 05, 2026 | LEONARD JOHN M | President and CEO | Sell | $314.48K |
| Jan 05, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | Sell | $78.36K |
| Jan 05, 2026 | BASTA JAMES | EVP, General Counsel | Sell | $95.76K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 1 | 9 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | 1 | 4 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 11 |
NTLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools